.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Johnson and Johnson
UBS
Julphar
Healthtrust
Deloitte
AstraZeneca
Cerilliant
US Army
Merck

Generated: July 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis
Abstract:Use of 2-amino-6-(trifluoromethoxy)benzothiazole, or a salt of this compound with a pharmaceutically acceptable acid, for obtaining a medicament intended for the treatment of motor neuron diseases, in particular amyotrophic lateral sclerosis, and especially amyotrophic lateral sclerosis with early bulbar involvement or the bulbar form of the disease.
Inventor(s): Louvel; Erik (Manosque, FR)
Assignee: Rhone Poulenc Rorer S.A. (FR)
Application Number:08/327,343
Patent Claims: 1. A method for treating a mammal with amyotrophic lateral sclerosis, comprising the step of administering to said mammal in recognized need of said treatment an effective amount of 2-amino-6-(trifluoromethoxy)benzothiazole or a pharmaceutically acceptable salt thereof.

2. The method according to claim 1 wherein said amyotrophic lateral sclerosis is with early bulbar involvement.

3. The method according to claim 1 wherein said amyotrophic lateral sclerosis is the bulbar form.

4. The method according to claim 1, wherein said effective amount comprises 25 to 200 mg of said 2-amino-6-(trifluoromethoxy)benzothiazole or said salt thereof.

5. The method according to claim 4, wherein said effective amount comprises 50 mg.

6. The method according to claim 4, wherein said effective amount comprises 25 mg.

7. The method according to claim 1, wherein said effective amount comprises 50 to 400 mg of said 2-amino-6-(trifluoromethoxy)benzothiazole or said salt thereof.

8. The method according to claim 4, wherein said effective amount comprises 200 mg.

9. The method according to claim 1, wherein said effective amount comprises 400 mg.

10. The method according to claim 1, wherein said 2-amino-6-(trifluoromethoxy)benzothiazole or said salt thereof is administered along with a pharmaceutically acceptable carrier.

11. The method according to claim 1, wherein said 2-amino-6-(trifluoromethoxy)benzothiazole or said salt thereof is administered along with a pharmaceutically compatible product.

12. The method according to claim 4, wherein said effective amount comprises 100 mg.

13. The method according to claim 1, wherein said pharmaceutically acceptable salt is an acid addition salt.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Merck
Chinese Patent Office
Teva
Argus Health
AstraZeneca
Federal Trade Commission
Cerilliant
Healthtrust
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot